Healthcare -
Biotechnology - NASDAQ - US
$ 3.475
-5.83 %
$ 295 M
Market Cap
-2.94
P/E
TERN - CAPITAL EXPENDITURES
Capital Expenditures TERN - Terns Pharmaceuticals, Inc.
-52 K
LAST VALUE
60.89%
2 YEAR CAGR
26.60%
5 YEAR CAGR
0.00%
10 YEAR CAGR